Product Name | NebuSelect™ Recombinant Human CXCL13/BCA-1, His-Sumo-tag |
---|---|
Catalog Number | NBL-240596 |
Alias/Synonyms | CXCL13/BCA-1 |
Appearance | see COA |
Molecule Weight | Val23-Pro109 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | O43927 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240596-100ug | 100ug | Inquire | Inquire | |
NBL-240596-1mg | 1mg | Inquire | Inquire | |
NBL-240596-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CXCL13/BCA-1, His-Sumo-tag
Catalog#:
NBL-240596
Description:
NebuSelect™ Recombinant Human CXCL13/BCA-1, His-Sumo-tag(Cat#NBL-240596) is expressed in E.coli with His tag and Sumo tag at the N-Terminus.It contains Val23-Pro109.
Species:
Human
Expression System:
E.coli
Molecular Weight:
The protein has a predicted MW of 22.9 kDa. The protein migrates to 26-28 kDa based on Bis-Tris PAGE result.
Target Name:
CXCL13/BCA-1
Target Information:
Recent studies have implicated chemokines in microglial activation and pathogenesis of neuropathic pain. C-X-C motif chemokine 13 (CXCL13) is a B lymphocyte chemoattractant that activates CXCR5. Using the spinal nerve ligation (SNL) model of neuropathic pain, CXCL13 was persistently upregulated in spinal cord neurons after SNL, resulting in spinal astrocyte activation via CXCR5 in mice.
Amino Acid Sequence:
Val23-Pro109
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.